26 related articles for article (PubMed ID: 19464189)
1. Novel 1,4-diarylpiperidine-4-methylureas as anti-hyperlipidemic agents: dual effectors on acyl-CoA:cholesterol O-acyltransferase and low-density lipoprotein receptor expression.
Asano S; Ban H; Kino K; Ioriya K; Muraoka M
Bioorg Med Chem Lett; 2009 Feb; 19(4):1062-5. PubMed ID: 19167888
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA:cholesterol O-acyltransferase inhibitors.
Romeo G; Salerno L; Milla P; Siracusa M; Cattel L; Russo F
Pharmazie; 1999 Jan; 54(1):19-23. PubMed ID: 9987793
[TBL] [Abstract][Full Text] [Related]
3. A novel class of antihyperlipidemic agents with low density lipoprotein receptor up-regulation via the adaptor protein autosomal recessive hypercholesterolemia.
Asano S; Ban H; Tsuboya N; Uno S; Kino K; Ioriya K; Kitano M; Ueno Y
J Med Chem; 2010 Apr; 53(8):3284-95. PubMed ID: 20356098
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibitors of acyl-CoA:cholesterol acyltransferase. 2. Structure-activity relationships of novel N-(2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)amides.
Kataoka K; Shiota T; Takeyasu T; Minoshima T; Watanabe K; Tanaka H; Mochizuki T; Taneda K; Ota M; Tanabe H; Yamaguchi H
J Med Chem; 1996 Mar; 39(6):1262-70. PubMed ID: 8632433
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship studies on a novel series of naphthylidinoylureas as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT).
Ohnuma S; Muraoka M; Ioriya K; Ohashi N
Bioorg Med Chem Lett; 2004 Mar; 14(5):1309-11. PubMed ID: 14980688
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of N-(4-amino-2,6-diisopropylphenyl)-N'-(1,4-diarylpiperidine-4-yl)methylureas as anti-hyperlipidemic agents.
Asano S; Ban H; Kino K; Ioriya K; Muraoka M
Bioorg Med Chem; 2009 Jul; 17(13):4636-46. PubMed ID: 19464189
[TBL] [Abstract][Full Text] [Related]
7. Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
Tomoda H; Doi T
Acc Chem Res; 2008 Jan; 41(1):32-9. PubMed ID: 17803269
[TBL] [Abstract][Full Text] [Related]
8. Regulation of triglyceride metabolism. I. Eukaryotic neutral lipid synthesis: "Many ways to skin ACAT or a DGAT".
Turkish A; Sturley SL
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G953-7. PubMed ID: 17095752
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic?
López-Farré AJ; Sacristán D; Zamorano-León JJ; San-Martín N; Macaya C
Cardiovasc Ther; 2008; 26(1):65-74. PubMed ID: 18466422
[TBL] [Abstract][Full Text] [Related]
10. Urea derivatives on the move: cytokinin-like activity and adventitious rooting enhancement depend on chemical structure.
Ricci A; Bertoletti C
Plant Biol (Stuttg); 2009 May; 11(3):262-72. PubMed ID: 19470099
[TBL] [Abstract][Full Text] [Related]
11. ACAT inhibition: bad for macrophages, good for smooth muscle cells?
Fazio S; Dove DE; Linton MF
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):7-9. PubMed ID: 15626766
[No Abstract] [Full Text] [Related]
12. JTT-705. Japan Tobacco.
Linders JT
Curr Opin Investig Drugs; 2004 Mar; 5(3):339-43. PubMed ID: 15083602
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
